Erratum: Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency (Oncology Letters (2020) 19 (3789-3798) DOI: 10.3892/ol.2020.11479)

Jinhuan Wang, Zhaoyi Miao, Yanan Jiang, Ping Zou, Weiming Li, Xiaoqiong Tang, Yangyang Lv, Donghui Xing, Shi Chen, Fengchun Yang, Mingjiang Xu, Zeng Cao, Haitao Wang, Zhigang Zhao

Resultado de la investigación: Comment/debaterevisión exhaustiva

1 Cita (Scopus)

Resumen

Subsequently to the publication of the above article, the authors have realized that three of the four fluorescence-activated cell sorting (FACS) images in Fig. 2B were selected incorrectly. Furthermore, the pie charts shown in Fig. 3A were labelled incorrectly; essentially, the pie charts from left to right should have been labelled as 'Myeloid malignancy' and 'Normal', respectively). Corrected versions of Figs. 2 and 3 are shown on the next page. The authors would like to thank the Editor of Oncology Letters for allowing them the opportunity to publish this corrigendum, and apologize to the readership of the Journal for any inconvenience caused.

Idioma originalEnglish (US)
Número de artículoe11907
PublicaciónOncology Letters
Volumen20
N.º4
DOI
EstadoPublished - oct 2020
Publicado de forma externa

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Huella

Profundice en los temas de investigación de 'Erratum: Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency (Oncology Letters (2020) 19 (3789-3798) DOI: 10.3892/ol.2020.11479)'. En conjunto forman una huella única.

Citar esto